MedTrace Logo

Three-Dimensional Ultrasonography Versus Magnetic Resonance Imaging for Fibroid Mapping: A Cross Sectional Observational Study

NCT05505331 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-08-17

No results posted yet for this study

Summary

Three-Dimensional Ultrasonography versus Magnetic Resonance Imaging for Fibroid Mapping: A Cross sectional Observational study

Conditions

  • Three-Dimensional Ultrasonography Versus Magnetic Resonance Imaging for Fibroid Mapping

Interventions

RADIATION

three-Dimensional ultrasonography

transadominal and transvaginal examination

RADIATION

Magnetic resonance imaging

multiplanar T2-weighted sequences and pre-contrast T1-weighted imaging in either the sagittal or axial plane

PROCEDURE

myomectomy

myoma excision

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
12 Years
Max Age
52 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-15
Primary Completion
2023-05-31
Completion
2023-07-31
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05505331 on ClinicalTrials.gov